13 February 2024
PanTera and Bayer Sign Actinium-225 Supply Agreement
Starting in late 2024, PanTera will supply actinium-225, enhancing access for clinical trials and developing a large-scale production facility to meet global demand for radiopharma-based cancer treatments.
